The opioid crisis continues to loom in healthcare, as more individuals become addicted to and die from lawful and illegal forms of opioids. While controlled substances such as heroin are to blame for much of the problem, prescription medications are also a contributor. Variation in how physicians treat chronic pain and non-nerve-related back pain and […]
Category: Prescription Drugs
The 21st Century Cures Act, the opioid crisis, and the cost of pharmaceuticals dominated the headlines of 2016, highlighting the importance of understanding how prescription drugs work in today’s healthcare industry. One valuable tool used by employers, health plans and pharmacists is Drug Utilization Review (DUR). AMR created a quick reference guide to DUR so you […]
Prescription drug coverage is changing in 2017, with new specific rules for the exceptions process. Take a look at our latest infographic to find out how the exceptions process may affect your prescription!
We’re all familiar with the flu, the cold weather specter that sends us all scurrying to the nearest pharmacy for a yearly flu shot. The flu is mostly preventable, but the need for a yearly vaccination can become tedious, and many people skip it altogether. The reason people find themselves at the pharmacy to get […]
Approximately 43.6 million adults in the U.S. suffer from some type of mental illness, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). That is more than 18 percent of the U.S. population. At that rate, it’s nearly impossible for someone to go their whole lives without either experiencing mental illness first hand […]
AMR’s latest infographic looks at the both the benefits and concerns of Biosimilar drugs.
In the U.S., prescriptions for and sales of opioid painkillers have nearly quadrupled since 1999, according to the Centers for Disease Control and Prevention. Researchers from the University of Michigan Medical School and the Department of Veterans Affairs’ Ann Arbor Healthcare System published a new study in the online journal Medical Care exposing a major […]
The U.S. Food and Drug Administration has a rigorous drug approval method, but recent years have shown that even this thorough process undergoes certain trends. Each year more new drug applications (NDA) are submitted and approved, including specialty drugs. The annual increase in the approval rates of novel and specialty drugs may signal a general […]
Not every aspect of the shifting health care market is clear, but one thing is for certain: The importance of pharmacy benefit management companies (PBMs) is increasing. Drug prices are rising, and PBMs continue to act as intermediaries between insurance companies, pharmacies and manufacturers to reduce prices for insurers and patients whenever possible. PBMs have […]
We’ve become familiar, and even comfortable, with the concept of generic drugs. These medications are identical, or “bioequivalent,” to a brand-name pharmaceutical. According to the U.S. Food and Drug Administration, generics must be chemically identical to and match the branded drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended […]